These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3841515)

  • 1. Positive effect of bromocriptine treatment in Graves disease orbitopathy.
    Kołodziej-Maciejewska H; Reterski Z
    Exp Clin Endocrinol; 1985 Dec; 86(2):241-2. PubMed ID: 3841515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
    Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
    Wuttke H; Schlieter D
    Med Klin; 1980 Aug; 75(18):658-62. PubMed ID: 6158667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group.
    Benker G; Kahaly GJ; Reinwein D
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S186-9. PubMed ID: 10614919
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-dependent effect of cyclosporin-A on the TSH-receptor antibody synthesis in patients with Graves' disease.
    Balázs C; Kiss E; Farid NR
    Acta Med Hung; 1988; 45(1):43-52. PubMed ID: 3412862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of possible antiidiotypic control mechanisms in Graves' disease.
    Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
    J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased secretion of gonadotropins in a patient with Graves' disease.
    Hakamata M; Itoh M; Sudo Y; Katada E; Miyata N
    Exp Clin Endocrinol Diabetes; 1996; 104(1):85-8. PubMed ID: 8750576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsional diplopia in Graves' orbitopathy. Three case reports.
    Vandelanotte S; De Clippeleir L; Dieltiens M; Van Lammeren M
    Bull Soc Belge Ophtalmol; 2003; (288):33-9. PubMed ID: 12879723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
    Gopinath B; Wescombe L; Nguyen B; Wall JR
    Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium in the preoperative preparation of Graves' disease.
    Takami H
    Int Surg; 1994; 79(1):89-90. PubMed ID: 8063564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid storm with encephalopathic symptoms due to Graves' disease and inappropriate secretion of thyrotropin.
    Modignani RL; Venegoni M; Beretta F; Fassina S
    Ann Ital Med Int; 1992; 7(4):250-4. PubMed ID: 1298337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine therapy for thyroid ophthalmopathy.
    Lopatynsky MO; Krohel GB
    Am J Ophthalmol; 1989 Jun; 107(6):680-1. PubMed ID: 2729418
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment of thyroid-associated orbitopathy.
    Prummel MF
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S198-200. PubMed ID: 10614922
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient retinal arterial compromise in Graves' orbitopathy.
    Ghabrial R; Francis IC; Fulcher GR
    Eye (Lond); 1998; 12 ( Pt 3a)():477-9. PubMed ID: 9775254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.